Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Butterfly Network Inc (BFLY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/13/2025: BFLY (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.17
1 Year Target Price $3.17
| 4 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.77% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 349.92M USD | Price to earnings Ratio - | 1Y Target Price 3.17 |
Price to earnings Ratio - | 1Y Target Price 3.17 | ||
Volume (30-day avg) 4 | Beta 2.46 | 52 Weeks Range 0.90 - 4.98 | Updated Date 08/13/2025 |
52 Weeks Range 0.90 - 4.98 | Updated Date 08/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.28 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-07-30 | When Before Market | Estimate -0.06 | Actual -0.03 |
Profitability
Profit Margin -71.78% | Operating Margin (TTM) -60.36% |
Management Effectiveness
Return on Assets (TTM) -13.72% | Return on Equity (TTM) -29.42% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 223436114 | Price to Sales(TTM) 4 |
Enterprise Value 223436114 | Price to Sales(TTM) 4 | ||
Enterprise Value to Revenue 2.55 | Enterprise Value to EBITDA -9.57 | Shares Outstanding 225314000 | Shares Floating 193717286 |
Shares Outstanding 225314000 | Shares Floating 193717286 | ||
Percent Insiders 13.97 | Percent Institutions 47.19 |
Upturn AI SWOT
Butterfly Network Inc
Company Overview
History and Background
Butterfly Network, Inc. was founded in 2011 with the goal of democratizing medical imaging through a single, affordable handheld whole-body ultrasound device. It went public in February 2021 via a SPAC merger with Longview Acquisition Corp II.
Core Business Areas
- Ultrasound Imaging: Develops and commercializes the Butterfly iQ+ and Butterfly iQ3, handheld, whole-body ultrasound devices.
- Software and AI: Offers a software platform providing AI-powered image capture guidance, image interpretation tools, and workflow solutions.
- Education and Training: Provides educational resources and training programs for healthcare professionals to effectively use their ultrasound technology.
Leadership and Structure
Dr. Todd Fruchterman serves as President and Chief Executive Officer. The company has a typical corporate structure with departments focusing on R&D, sales, marketing, and operations.
Top Products and Market Share
Key Offerings
- Butterfly iQ+: A handheld, single-probe whole-body ultrasound imaging device. Market share data is difficult to pinpoint precisely but its market presence is growing. Competitors include GE Healthcare, Philips, and Siemens Healthineers. It has more than 100,000 users.
- Butterfly iQ3: The latest genaration of the handheld, single-probe whole-body ultrasound imaging device. Improved image quality and AI guidance. Market share data is difficult to pinpoint precisely but its market presence is growing. Competitors include GE Healthcare, Philips, and Siemens Healthineers
- Butterfly Cloud: A secure, HIPAA-compliant cloud platform for image storage, collaboration, and AI-powered analysis. No direct revenue data available.
Market Dynamics
Industry Overview
The medical imaging market is experiencing growth, driven by technological advancements, an aging population, and increased demand for point-of-care diagnostics.
Positioning
Butterfly Network aims to disrupt the traditional ultrasound market by offering a more affordable and accessible solution. Its competitive advantages lie in its low cost and ease of use.
Total Addressable Market (TAM)
The global ultrasound market is estimated to be worth billions of dollars. Butterfly Network is positioned to capture a significant portion of this TAM by targeting underserved markets and expanding the use of ultrasound in various clinical settings.
Upturn SWOT Analysis
Strengths
- Affordable and accessible technology
- Innovative single-probe design
- Strong software platform
- FDA cleared
Weaknesses
- Image quality may not match high-end traditional systems
- Limited brand recognition compared to established players
- Relatively new company with a limited track record
- Dependence on third-party manufacturers
Opportunities
- Expanding into underserved markets
- Developing new AI-powered applications
- Partnering with healthcare providers
- Integration with electronic health records
Threats
- Competition from established medical imaging companies
- Technological advancements by competitors
- Regulatory changes
- Economic downturns
Competitors and Market Share
Key Competitors
- GE (GE)
- Philips (PHG)
- Siemens Healthineers (SIE.DE)
Competitive Landscape
Butterfly Network's advantage is its lower price point. However, its disadvantages are the higher image quality of competitors and lower brand recognition.
Growth Trajectory and Initiatives
Historical Growth: Butterfly Network has shown revenue growth in recent years.
Future Projections: Analysts forecast continued revenue growth, driven by increased adoption of the Butterfly iQ+ and expansion into new markets. Profitability is uncertain.
Recent Initiatives: Recent initiatives include product upgrades (Butterfly iQ3), expansion of AI capabilities, and partnerships with healthcare systems.
Summary
Butterfly Network is a promising company disrupting the ultrasound market with its affordable technology. While its current market share is limited and it faces challenges from established players, its innovative approach and focus on accessibility position it for future growth. Improving image quality and expanding its customer base are crucial. The company needs to demonstrate a clear path to profitability to ensure long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, industry reports, analyst estimates
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Butterfly Network Inc
Exchange NYSE | Headquaters Burlington, MA, United States | ||
IPO Launch date 2020-07-13 | CEO, President & Chairman of the Board Mr. Joseph M. DeVivo | ||
Sector Healthcare | Industry Medical Devices | Full time employees 190 | Website https://www.butterflynetwork.com |
Full time employees 190 | Website https://www.butterflynetwork.com | ||
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly iQ+ Bladder, a specialty product for the bladder scanning market; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. It also provides Butterfly system, which includes probes, related accessories, and software subscriptions to healthcare systems, physicians, and healthcare providers. In addition, the company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments; and ScanLab, an education-only app that provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. It sells its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.